AI Insight
Researchers developed sugar-coated nanoparticles to deliver genetic material across the blood-brain barrier into glioblastoma cells, restoring a tumor-suppressing protein. In mouse models, this experimental therapy increased median survival time by 50% and reduced tumor size without apparent damage to healthy organs. The sugar coating allows the nanoparticles to bypass the brain's protective barrier, which typically blocks most therapeutic agents.
Why it matters
Glioblastoma is one of the most lethal brain cancers with limited treatment options, partly because the blood-brain barrier prevents most drugs from reaching tumors. This nanoparticle delivery system could enable new gene-based therapies for brain cancers and potentially other neurological diseases that are currently difficult to treat.
Understand the Science
A new experimental treatment may have found a way to outsmart glioblastoma’s toughest defense: the blood-brain barrier. Researchers used sugar-coated nanoparticles to ferry genetic instructions that restore a key tumor-suppressing protein directly into brain cancer cells. In mouse studies, the therapy increased median survival by 50% while shrinking tumors without noticeable damage to other organs.
Source: This sugar-coated therapy boosted survival against deadly brain cancer by 50% in mice